Consensus EPS · Q4 2026
$0.52
Consensus revenue · Q4 2026
$314.3M
Analysts
9
Expected report
Aug 5, 2026
What to watch
- Analyst ratings: Mixed
Analyst consensus
Based on estimates from 9 analysts.
| Metric | Low | Consensus | High |
|---|---|---|---|
| Revenue | $310.8M | $314.3M | $317.9M |
| EPS | $0.51 | $0.52 | $0.53 |
| EBITDA | $88.6M | $93.9M | $110.8M |
| EBIT | $60.9M | $64.5M | $76.2M |
| Net income | $78.6M | $81.7M | $83.2M |
Historical beat/miss
Actual reported results vs. analyst consensus at the time. Positive = beat, negative = miss.
| Period | Rev. actual | Rev. est. | Rev. surprise | EPS actual | EPS est. | EPS surprise |
|---|---|---|---|---|---|---|
| Q3 2026 | $311.4M | $316.1M | −1.5% | $0.53 | $0.53 | −0.8% |
Estimate revisions
How analyst consensus estimates have changed over the past 90 days.
| Metric | Now | 30d ago | 60d ago | 90d ago | 30d Δ |
|---|---|---|---|---|---|
| Revenue | $318.1M | — | — | — | — |
| EPS | $0.50 | — | — | — | — |
Community vs analysts
See how the TickerLeague crowd's forecast stacks up against Wall Street.
Be the first to predict
No community consensus for Bio-Techne (TECH) Q4 2026 yet. Make a prediction to start the crowd forecast.
Analyst price target
Based on price targets from 1 analyst.
| Low | Consensus | Median | High | Current | Upside |
|---|---|---|---|---|---|
| $49.00 | $59.17 | $56.00 | $79.00 | $57.94 | +2.1% |
Upside calculated vs most recent trading price of $57.94.
Analyst ratings
Consensus: Buy — based on 25 analyst ratings.
24-month trend
Recent analyst actions
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| May 7, 2026 | Wells Fargo | maintain | Overweight | Overweight |
| May 7, 2026 | Evercore ISI Group | maintain | In Line | In Line |
| May 7, 2026 | Citigroup | maintain | Buy | Buy |
| Apr 6, 2026 | Evercore ISI Group | maintain | In Line | In Line |
| Feb 6, 2026 | Wells Fargo | maintain | Overweight | Overweight |
| Feb 5, 2026 | UBS | maintain | Buy | Buy |
| Feb 5, 2026 | TD Cowen | maintain | Buy | Buy |
| Feb 5, 2026 | Stifel | maintain | Hold | Hold |
| Feb 5, 2026 | Evercore ISI Group | maintain | In Line | In Line |
| Feb 5, 2026 | Citigroup | maintain | Buy | Buy |
Frequently asked questions
Bio-Techne (TECH) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation